I've been expecting an announcement soon to confirm that the trial has kicked off, but the volume today might imply its something more than that.
Also curious to see if the agreement with In2Pharma in Feb has started paying off in terms of increased pharmacy footprint (and in turn increased sales). Recent presentations haven't shown a significant boost in pharmacy numbers which could be attributed to In2Pharma but hopefully they are getting some traction now.
BDA Price at posting:
52.0¢ Sentiment: Buy Disclosure: Held